Pharma Journalist - Page 827 of 829 -

5th Genome Editing Therapeutics Summit is only 3 weeks away!

Datopotamab Deruxtecan BLA Submitted for Accelerated Approval in the U.S. for Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Nippon Shinyaku and Atsena Therapeutics enter into an Exclusive Strategic Collaboration for ATSN-101 in the U.S. and Japan

BMS Selects Medidata Clinical Cloud to Drive Drug Development & Business Transformation

GlaxoSmithKline Selects TierPoint to Support Global Data Consolidation and Recovery Operations

Halo Pharmaceutical, ExxPharma partner to develop products using Twin Screw Extrusion technology

Oracle Delivers Complete Cloud Solution to Help Pharma Companies Improve Drug Safety

Supernus Pharmaceuticals Selects DSG, Inc. for EDC and IWRS in Phase 3 Clinical Studies

Eisai Signs Three-Year Contract Extension For CSC’s TRS as-a-Service

Marina Biotech Announces a License Agreement to Deliver a Genome Editing Technology

New England Biolabs Selects Symmetry for Comprehensive SAP HANA Cloud Migration

Medidata’s Cloud Technology Powers U.S. Government Research on Drug Development Costs

Grünenthal selects Patheon to develop drugs using INTAC abuse deterrent formulations technology